Literature DB >> 9037618

The toxins of group A streptococcus, the flesh eating bacteria.

D L Stevens1.   

Abstract

Streptococcus pyogenes causes a wide variety of infections in individuals of all ages in most countries of the world. Because of the frequency with which these infections occur, physicians are quite familiar with the diversity of clinical presentations associated with the Group A streptococcus. Yet in the late 1980's, a severe form of streptococcal infection, the Streptococcal Toxic Shock Syndrome, emerged and has persisted for the last 10 years. This syndrome is associated with invasive soft tissue infections and the early onset of shock and organ failure. The purpose of this paper is to briefly describe the epidemiologic and clinical features of the Streptococcal Toxic Shock Syndromes and to emphasize the role that toxins produced by S. pyogenes play in the pathogenesis of this disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9037618     DOI: 10.3109/08820139709048921

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  4 in total

1.  Hypothesis: is a failure to prevent bacteriolysis and the synergy among microbial and host-derived pro-inflammatory agonists the main contributory factors to the pathogenesis of post-infectious sequelae?

Authors:  I Ginsburg
Journal:  Inflammation       Date:  2001-02       Impact factor: 4.092

2.  Reciprocal, temporal expression of SpeA and SpeB by invasive M1T1 group a streptococcal isolates in vivo.

Authors:  S U Kazmi; R Kansal; R K Aziz; M Hooshdaran; A Norrby-Teglund; D E Low; A B Halim; M Kotb
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  Doubly branched hexasaccharide epitope on the cell wall polysaccharide of group A streptococci recognized by human and rabbit antisera.

Authors:  Francis Michon; Samuel L Moore; John Kim; Milan S Blake; France-Isabelle Auzanneau; Blair D Johnston; Margaret A Johnson; B Mario Pinto
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

4.  An anti-perfringolysin O monoclonal antibody cross-reactive with streptolysin O protects against streptococcal toxic shock syndrome.

Authors:  Takayuki Matsumura; Ayae Nishiyama; Michio Aiko; Akira Ainai; Tadayoshi Ikebe; Joe Chiba; Manabu Ato; Yoshimasa Takahashi
Journal:  BMC Res Notes       Date:  2020-09-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.